Impact of Admission Glycosylated Hemoglobin A1c on Angiographic Characteristics and Short Term Clinical Outcomes of Nondiabetic Patients with Acute ST-Segment Elevation Myocardial Infarction

Table 3

Adverse cardiac events in the study groups according to HbA1c.

Level of glycosylated hemoglobin
Adverse cardiac events; (NO) %	Group (); <6.5%; ()	Group (); 6.5%–8.5%; ()	Group (); >8.5%; ()	value
Reinfarction	()	()	()	0.04
	7.4%	5.9%	12.5%
Mortality	()	()	()
	7.4%	11.8%	37.5%
Heart failure	()	()	()
	3.7%	5.9%	12.5%
No cardiac events	()	()	()
	81.5%	76.5%	37.5%